Prediction of Chemotherapy Response and Patient Prognosis in Non-small Cell Lung Cancer: Dynamic Contrast-enhanced MRI and Diffusion-weighted Imaging Versus Volume-based Parameter of 18F-FDG PET
Sponsor study identifier
observational
35
1 country
1
Study Start
November 2011
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2013
Actual (reported)Study Completion
January 2014
Actual (reported)In this prospective study, the investigators will evaluate and compare the usefulness of functional and volumetric informations obtained by 18F-FDG PET and MRI before and after the palliative chemotherapy with the aim of predicting tumor response and prognosis in patients with advanced Non-small Cell Lung Cancer (NSCLC).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2014
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 2011
Date type not reportedThis date has not been verified as actual or estimated.
November 17, 2011
Actual (reported)November 30, 2011
Actual (reported)November 2013
Actual (reported)January 2014
Actual (reported)DWI, DCE-MRI, and FDG PET as early predictor for response and prognosis
The primary endpoint of this study is the prediction of one-year overall survival by monitoring the metabolic and functional responses of the tumor following one cycle of chemotherapy.
one year
Correlation among DWI, DCE-MRI, and FDG PET and relationship with prognosis
one year
Correlation among DWI, DCE-MRI, and FDG PET and relationship with prognosis
one year
patients with advanced NSCLC
Samsung Medical Center
Seoul, South Korea
Ho Yun Lee, Dr.
Samsung Medical Center
35 participants (actual enrollment reported by the registry).
First Submitted
November 17, 2011
First Posted
November 30, 2011
Study Start
November 2011
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Primary Completion
November 2013
Actual (reported)Study Completion
January 2014
Actual (reported)Last Updated
November 20, 2015
Record last verified: 2015-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: